![Anand Patel: Myeloid neoplasms after MTX have features more similar to de-novo](https://oncodaily.com/pub/uploads/2024/07/aca18f3156a64ebeb39fb7785c37d6ed-e1724057891564.jpg)
Photo from Anand Patel/X
Jul 24, 2024, 00:57
Anand Patel: Myeloid neoplasms after MTX have features more similar to de-novo
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a post on X/Twitter:
“We often discuss if myeloid neoplasms after MTX therapy have high-risk features/cytogenetics – this report found myeloid neoplasms after MTX have features more similar to de-novo disease than t-MN.”
Source: Anand Patel/X
Authors: Mihir D. Wechalekar, Lin-Pierre Zhao, Monika M. Kutyna, Lih En Hong, Joule Li, Kevin Hung, Hamish S. Scott, Anna Brown, Christopher C. Hahn, Karin Kassahn, Dariusz Ladon, David T. Yeung, Daniel Thomas, Mrinal Patnaik, Susanna Proudman, Lionel Ades, Mithun V. Shah, Chung H. Kok and Devendra K. Hiwase
Anand Patel
Anna Brown
cancer
Christopher C. Hahn
Chung H. Kok
Daniel Thomas
Dariusz Ladon
David T. Yeung
Devendra K. Hiwase
Hamish S. Scott
Joule Li
Karin Kassahn
Kevin Hung
Lih En Hong
Lin-Pierre Zhao
Lionel Ades
Mihir D. Wechalekar
Mithun V Shah
Monika M. Kutyna
Mrinal Patnaik
MTX
myeloid neoplasms
OncoDaily
Oncology
Susanna Proudman
University of Chicago